Measures and markers in Amyotrophic Lateral Sclerosis
暂无分享,去创建一个
[1] A. Eisen,et al. Cortical Excitability in Amyotrophic Lateral Sclerosis: A Clue to Pathogenesis , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[2] J R Daube,et al. Estimating the Number of Motor Units in a Muscle , 1995, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[3] R. Tarducci,et al. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis , 2001, Neuroradiology.
[4] Stefano Tamburin,et al. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis , 2002, Journal of Neurology.
[5] M A Horsfield,et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS , 1999, Neurology.
[6] Lin Jin,et al. Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis , 1998, Neuron.
[7] P. Leigh,et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis , 1996, The Lancet.
[8] T. Deguchi,et al. A null mutation in the human CNTF gene is not causally related to neurological diseases , 1994, Nature Genetics.
[9] N. Hirokawa,et al. Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.
[10] J. Hauw,et al. The relationship between Bunina bodies, skein-like inclusions and neuronal loss in amyotrophic lateral sclerosis , 2002, Acta Neuropathologica.
[11] H. Schild,et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. , 2001, Archives of neurology.
[12] Marinos C. Dalakas,et al. Muscle biopsy — a practical approach , 1986, The Ulster Medical Journal.
[13] M W Weiner,et al. Decreased N‐acetylaspartate in motor cortex and corticospinal tract in ALS , 1998, Neurology.
[14] P. Andres,et al. Quantitative assessment of neuromuscular deficit in ALS. , 1987, Neurologic clinics.
[15] Volkmar Glauche,et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. , 2004, Brain : a journal of neurology.
[16] Robert H. Brown,et al. A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. , 2002, American journal of human genetics.
[17] N. Hirokawa,et al. Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.
[18] S H Appel,et al. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. , 1995, Brain : a journal of neurology.
[19] W. Bradley,et al. Amyotrophic lateral sclerosis: the search for a spectroscopic marker of upper motoneuron involvement. , 2001, Archives of neurology.
[20] Mb Alan J. McComas Dr.,et al. The extent and time course of motoneuron involvement in amyotrophic lateral sclerosis. , 1991 .
[21] E. Sorenson. Great Lakes ALS Study Group , 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[22] D. Shungu,et al. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. , 1999, Radiology.
[23] F. Weber,et al. Matrix metalloproteinase‐9 is elevated in serum of patients with amyotrophic lateral sclerosis , 2000, Neuroreport.
[24] M. Bromberg,et al. Sources of error in the spike‐triggered averaging method of motor unit number estimation (MUNE) , 1995, Muscle & nerve.
[25] Jeffrey D. Rothstein,et al. From charcot to lou gehrig: deciphering selective motor neuron death in als , 2001, Nature Reviews Neuroscience.
[26] M. Pericak-Vance,et al. Erratum: The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis (Nature Genetics (2001) 29 (160-165)) , 2001 .
[27] A. Kakita,et al. Neuropathology with Clinical Correlations of Sporadic Amyotrophic Lateral Sclerosis: 102 Autopsy Cases Examined Between 1962 and 2000 , 2003, Brain pathology.
[28] J. Veldink,et al. A randomized sequential trial of creatine in amyotrophic lateral sclerosis , 2003, Annals of neurology.
[29] V. Meininger,et al. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. , 1999, Archives of neurology.
[30] M. Beal,et al. Increased oxidative damage to DNA in ALS patients. , 2000, Free radical biology & medicine.
[31] A. Siderowf,et al. Postural change of forced vital capacity predicts some respiratory symptoms in ALS , 2001, Neurology.
[32] K. Mills,et al. Magnetic brain stimulation: Central motor conduction studies in multiple sclerosis , 1987, Annals of neurology.
[33] C. Armon,et al. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials 1 Presented in part at the 8th International Symposium on ALS/MND held in Glasgow, Scotland, November 3–5th, 1997. 1 , 1998, Journal of the Neurological Sciences.
[34] E. Sorenson. A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis , 2003, Neurology.
[35] Orla Hardiman,et al. Assessing individual quality of life in amyotrophic lateral sclerosis , 2004, Quality of Life Research.
[36] R. Olney,et al. Longitudinal study of fiber density and motor unit number estimate in patients with amyotrophic lateral sclerosis , 1997, Neurology.
[37] P. F. Kauff. Group , 2000, Elegant Design.
[38] M. Tamaki,et al. A loss of functional spinal alpha motor neurons in amyotrophic lateral sclerosis , 1998, Neurology.
[39] J. Belleroche,et al. Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis , 1995, Journal of the Neurological Sciences.
[40] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[41] J. Cedarbaum,et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.
[42] V. Meininger,et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.
[43] G. Parry,et al. A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis , 1996 .
[44] J. Coyle,et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.
[45] D. W. Mulder. Clinical limits of amyotrophic lateral sclerosis. , 1982, Advances in neurology.
[46] L. Krivickas,et al. Amyotrophic lateral sclerosis and other motor neuron diseases. , 2003, Physical medicine and rehabilitation clinics of North America.
[47] D. Arnold,et al. Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy. , 2003, AJNR. American journal of neuroradiology.
[48] R K Olney,et al. Comparison of multiple point and statistical motor unit number estimation , 2000, Muscle & nerve.
[49] Hiroshi Tsukagoshi,et al. Morphometric quantification of the cervical limb motor cells in controls and in amyotrophic lateral sclerosis , 1979, Journal of the Neurological Sciences.
[50] M. Mattson,et al. Presence of 4‐hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis , 1998, Annals of neurology.
[51] Robert H. Brown,et al. Decreased Metallation and Activity in Subsets of Mutant Superoxide Dismutases Associated with Familial Amyotrophic Lateral Sclerosis* 210 , 2002, The Journal of Biological Chemistry.
[52] D. Clifford,et al. Lamotrigine for HIV-associated painful sensory neuropathies , 2003, Neurology.
[53] N. Gonatas,et al. The Golgi apparatus is fragmented in spinal cord motor neurons of amyotrophic lateral sclerosis with basophilic inclusions , 2002, Acta Neuropathologica.
[54] M. Swash,et al. Clinical neurophysiology of ALS , 2001, Clinical Neurophysiology.
[55] L. Haverkamp,et al. Apolipoprotein E ɛ4 in bulbar-onset motor neuron disease , 1996, The Lancet.
[56] S. Kato,et al. Increased plasma TGF‐β1 in patients with amyotrophic lateral sclerosis , 2002, Acta neurologica Scandinavica.
[57] G. Parry,et al. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis , 1996, Neurology.
[58] W. Brown. Thenar motor unit count estimates in the carpel tunnel syndrome , 1973, Journal of neurology, neurosurgery, and psychiatry.
[59] E. Pioro. Proton magnetic resonance spectroscopy ( 1 H-MRS) in ALS , 2000 .
[60] A. Malafosse,et al. Association between centromeric deletions of the SMN gene and sporadic adult‐onset lower motor neuron disease , 1998, Annals of neurology.
[61] A. Pestronk,et al. Distal lower motor neuron syndrome with high‐titer serum IgM anti‐GM1 antibodies , 1994, Neurology.
[62] Hiroshi Mitsumoto,et al. Diagnosis and progression of ALS , 1997, Neurology.
[63] K. Toyka,et al. Comparison of maximal voluntary isometric contraction and Drachman's hand‐held dynamometry in evaluating patients with amyotrophic lateral sclerosis , 1999, Muscle & nerve.
[64] C. Elger,et al. Effect of Creatine Supplementation on Metabolite Levels in ALS Motor Cortices , 2001, Experimental Neurology.
[65] C. Wessig,et al. Creatine monohydrate in DM2/PROMM , 2003, Neurology.
[66] Shin J. Oh,et al. Mutant dynactin in motor neuron disease , 2003, Nature Genetics.
[67] P. Andres,et al. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis , 1988, Neurology.
[68] W. Brown,et al. Changes in motor unit populations in motor neurone disease. , 1979, Journal of neurology, neurosurgery, and psychiatry.
[69] F. H. Tyler,et al. Assessment of muscle strength in Duchenne muscular dystrophy , 1977, Neurology.
[70] Clifton L Gooch,et al. Motor unit number estimation. , 2003, Physical medicine and rehabilitation clinics of North America.
[71] Mark B. Bromberg,et al. Relationships between motor-unit number estimates and isometric strength in distal muscles in ALS/MND , 1996, Journal of the Neurological Sciences.
[72] S. Hansen,et al. A quantitative electrophysiological study of motor neurone disease. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[73] Robert H. Brown,et al. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis , 2003, Annals of neurology.
[74] T. Munsat,et al. Recombinant growth hormone treatment of amyotrophic lateral sclerosis , 1993, Muscle & nerve.
[75] Robert H. Brown,et al. Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis , 1997, Annals of neurology.
[76] N. Schuff,et al. Early detection and longitudinal changes in amyotrophic lateral sclerosis by 1H MRSI , 2002 .
[77] M. Pericak-Vance,et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis , 2001, Nature Genetics.
[78] M J Campbell,et al. Electrophysiological estimation of the number of motor units within a human muscle , 1971, Journal of neurology, neurosurgery, and psychiatry.
[79] T L Munsat,et al. Quantitative motor assessment in amyotrophic lateral sclerosis , 1986, Neurology.
[80] Robert H. Brown,et al. Apolipoprotein E ϵ4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis , 1995 .
[81] P. Sham,et al. Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. , 1996, Lancet.
[82] J. Powell,et al. Association of apolipoprotein E ∈4 allele with bulbar-onset motor neuron disease , 1996, The Lancet.
[83] T J Doherty,et al. Determinants of mean motor unit size: Impact on estimates of motor unit number , 1993, Muscle & nerve.
[84] M. Billiard,et al. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis , 1993, Acta neurologica Scandinavica.
[85] D. Arnold,et al. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo , 1994, Neurology.
[86] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[87] K. Mills,et al. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis , 1997, Muscle & nerve.
[88] L. F. Black,et al. Maximal respiratory pressures: normal values and relationship to age and sex. , 2015 .
[89] M. Naumann,et al. Disease progression in amyotrophic lateral sclerosis: Predictors of survival , 2002, Muscle & nerve.
[90] A. Pestronk,et al. Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation , 1994, Annals of neurology.
[91] J. Engstrom,et al. Statistical motor unit number estimation: Reproducibility and sources of error in patients with amyotrophic lateral sclerosis , 2000, Muscle & nerve.
[92] M. Brandstater,et al. Motor unit number estimate–based rates of progression of ALS predict patient survival , 1999, Muscle & nerve.
[93] D. Arnold,et al. A prospective, randomized, placebo‐controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[94] P. Urban,et al. Sensitivity of transcranial magnetic stimulation of cortico-bulbar vs. cortico-spinal tract involvement in Amyotrophic Lateral Sclerosis (ALS) , 2001, Journal of Neurology.
[95] M. Polkey,et al. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. , 2001, Brain : a journal of neurology.
[96] J. Shefner,et al. Reducing intersubject variability in motor unit number estimation , 1999, Muscle & nerve.
[97] J. Cedarbaum,et al. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials , 1997, Journal of the Neurological Sciences.
[98] A. McComas,et al. The extent and time course of motoneuron involvement in amyotrophic lateral sclerosis , 1991, Muscle and Nerve.
[99] Jeremy M. Shefner,et al. Motor unit number estimation in human neurological diseases and animal models , 2001, Clinical Neurophysiology.
[100] A. McComas,et al. Motor unit populations in healthy and diseased muscles. , 1993, Physical therapy.
[101] K. Roemer,et al. High rate of constitutional chromosomal rearrangements in apparently sporadic ALS , 2003, Neurology.
[102] P. Andres,et al. The natural history of motoneuron loss in amyotrophic lateral sclerosis , 1988, Neurology.
[103] J. Shefner,et al. Motor unit number estimation in neurologic disease. , 2002, Advances in neurology.
[104] K. Okamoto,et al. Reduction of the size of the Golgi apparatus of spinal anterior horn cells in patients with X‐linked spinal and bulbar muscular atrophy , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[105] H. Thoenen,et al. Disruption of the CNTF gene results in motor neuron degeneration , 1993, Nature.
[106] M. Province,et al. Clinical trials in Duchenne dystrophy. Standardization and reliability of evaluation procedures. , 1984, Physical therapy.
[107] G. Parry,et al. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis , 2001, Neurology.
[108] L. Rowland. Diagnosis of amyotrophic lateral sclerosis , 1998, Journal of the Neurological Sciences.
[109] M. Bromberg,et al. Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis , 1993, Muscle & nerve.
[110] Markus Weber,et al. Assessment of upper and lower motor neurons in Kennedy's disease: Implications for corticomotoneuronal PSTH studies , 1999, Muscle & nerve.
[111] T. Deguchi,et al. Erratum: A null mutation in the human CNTF gene is not causally related to neurological diseases , 1994, Nature Genetics.
[112] J. Cedarbaum,et al. Prognostic indicators of survival in ALS , 1998, Neurology.
[113] The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. , 1996, Archives of neurology.
[114] M. Iwata,et al. Ultrastructural study of Betz cells in the primary motor cortex of the human brain , 2001, Journal of anatomy.
[115] C. Andres,et al. Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis , 2002, Annals of neurology.
[116] T. Pabst,et al. 1H Spectroscopy in Patients With Amyotrophic Lateral Sclerosis , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[117] Jm Charcot,et al. Deux cas d’atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere , 1869 .
[118] D. Cleveland,et al. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[119] M. Mimura,et al. Constant involvement of the Betz cells and pyramidal tract in amyotrophic lateral sclerosis with dementia: a clinicopathological study of eight autopsy cases , 2002, Acta Neuropathologica.
[120] D. Borchelt,et al. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[121] D. Schoenfeld,et al. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis , 2003, Neurology.
[122] R. Sufit,et al. Design of clinical therapeutic trials in amyotrophic lateral sclerosis. , 1991, Advances in neurology.
[123] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[124] Michael Swash,et al. Early diagnosis of ALS/MND , 1998, Journal of the Neurological Sciences.
[125] Mulder Dw. Clinical limits of amyotrophic lateral sclerosis. , 1982 .
[126] L. Rowland. Human motor neuron diseases. , 1982, Advances in neurology.
[127] W. Paulus,et al. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis , 1997, Neurology.
[128] P M Pattany,et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. , 2000, AJNR. American journal of neuroradiology.
[129] J. Petajan,et al. Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis , 1997, Muscle & nerve.
[130] G. Smith,et al. A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience , 1987, Annals of neurology.
[131] C. Armon,et al. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis , 2000, Muscle & nerve.
[132] B. Crain,et al. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. , 1998, American journal of human genetics.
[133] K J Felice,et al. A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis , 1997, Muscle & nerve.
[134] Clifton L Gooch. Motor Unit Number Estimation: Pro , 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[135] W F Brown,et al. A method for estimating the number of motor units in thenar muscles and the changes in motor unit count with ageing , 1972, Journal of neurology, neurosurgery, and psychiatry.
[136] A. Malafosse,et al. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis , 1996, Journal of the Neurological Sciences.
[137] T. Ng,et al. 1H-MRS evidence of neurodegeneration and excess glutamate glutamine in ALS medulla , 1999, Neurology.
[138] A. Al-Chalabi,et al. Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: Homozygous naip deletion in a sporadic case , 1996, Annals of neurology.
[139] A. McComas,et al. Early and late losses of motor units after poliomyelitis. , 1997, Brain : a journal of neurology.